BamSEC and AlphaSense Join Forces
Learn More

Spyre Therapeutics Inc. – Indentures

NASDAQ: SYRE    
Share price (6/2/26): $69.16    
Market cap (6/2/26): $6.006 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from S-3 42 pages Spyre Therapeutics, Inc. Debt Securities Indenture Dated as of , 202 [ ], as Trustee
12/34/56
EX-4.2
from 10-Q 11 pages Spyre Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 10-Q 11 pages Spyre Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.2
from S-3 42 pages Spyre Therapeutics, Inc. Debt Securities Indenture Dated as of , 202 [ ], as Trustee
12/34/56
EX-4.6
from 10-K 11 pages Spyre Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.4
from 10-K 4 pages Description of Capital Stock
12/34/56
EX-4.2
from S-3 42 pages Spyre Therapeutics, Inc. Debt Securities Indenture Dated as of , 202 [ ], as Trustee
12/34/56
EX-4.2
from 10-Q 11 pages Spyre Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.5
from 10-K 4 pages Description of Capital Stock
12/34/56
EX-4.5
from S-1 11 pages Aeglea Biotherapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.4
from S-1 26 pages Registration Rights Agreement
12/34/56
EX-4.3
from S-1 62 pages Securities Purchase Agreement
12/34/56
EX-4.2
from S-1 2 pages Indenture or similar
12/34/56
EX-4.1
from S-1 22 pages Registration Rights Agreement
12/34/56
EX-4.5
from S-1/A 11 pages Aeglea Biotherapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.4
from S-1/A 26 pages Registration Rights Agreement
12/34/56
EX-4.3
from S-1/A 17 pages Registration Rights Agreement
12/34/56
EX-4.2
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.1
from S-1/A 54 pages Securities Purchase Agreement
12/34/56
EX-4.1
from 8-K 9 pages Aeglea Biotherapeutics, Inc. Form of Warrant to Purchase Common Stock
12/34/56